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Abstract
The U.S. Department of Health and Human Services Pain Management Best Practices
Interagency Task Force recommends procedure-specific, multimodal regimens and
therapies in the perioperative period. Historically, joint arthroplasty has been known to
require significant amounts of postoperative opioids to reduce pain and enable early
mobilization; however, side effects such as sedation, nausea, and vomiting can delay
early mobilization. Many accredited joint centers have adopted Enhanced Recovery
After Surgery programs (ERAS) to provide optimal analgesic effect with decreased
length of stay and narcotic consumption using a multimodal analgesic approach
encompassing opioid and nonopioid analgesia. Despite the promotion of ERAS, this
practice is not in place for hip arthroplasty at the clinical site, where treatment option is
dependent on each practitioner preference. The purpose of this retrospective chart review
was to determine whether there is a difference in postoperative opioid requirements and
pain levels in the first 24 inpatient hours in adults over the age of 60 undergoing primary
hip arthroplasty depending on the type of multimodal perioperative analgesia received. A
sample of 200 charts meeting the study criteria were reviewed and study variables
collected and analyzed using Excel. Results showed that 32% (n=64) of the 200 patients
received preoperative analgesia. Of those, 89% (n=59) received a preoperative dose of
acetaminophen. Compared to patients who did not receive preoperative analgesia, those
who had two multimodal analgesia had a lower dose average of opioid consumption and
pain scores within the first 24 hours postoperatively. The results underscore the benefits
of preoperative multimodal use. Collaboratively, APRN could work with surgeons to
implement ERAS, provide staff education, and evaluate pathway effectiveness.
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Preoperative Multimodal Analgesia in Total Hip Arthroplasty
Background/Statement of the Problem
Pain is defined as physical suffering caused from illness or injury (Pain, 2019). It
is a sensation people will experience in their lifetime. What degree of pain experienced is
based on each person’s perception of pain. During the 1990’s, those in healthcare began
to change their perspective on pain in response to the American Pain Society
recommendation that pain be assessed with the same intensity as other vital signs
(Koepke et al., 2018). The Veterans Affairs Hospital Systems reacted by requiring pain
be documented as the fifth vital sign, along with blood pressure, heart rate, respiration,
and temperature measurements (Koepke et al., 2018). The Joint Commission on
Accreditation of Healthcare Organizations (JCAHO) responded by educating health care
professionals on the how to perform pain assessments and appropriate documentation of
pain. In 2001, JCAHO required the documentation of pain on every patient. The
requirement of documentation and treatment of pain became an integral part of a patient’s
treatment plan. With the change in clinical practice, there emerged a dramatic reciprocal
increase in opioid prescriptions and overdoses (Hsu et al., 2019). In the year 1999, prior
to practice changes, a total of 6,009 narcotic overdoses were recorded nationally (Centers
for Disease Control and Prevention Web-based Injury Statistics Query and Reporting
System [CDC WISQARS], 2019a). Most recent national statistics demonstrate a
dramatic increase, with a total of 29,288 deaths from narcotic overdose in 2017 (CDC
WISQARS, 2019b). This indicates an almost five-fold increase within 18 years.
In the 1990s there was an increase in opioid prescriptions with a reciprocal
increase in opioid overdoses from natural and semi-synthetic opioids and methadone.
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This increase in opioid overdose deaths continued to rise until 2016, in which the death
rate plateaued. In 2013 there was an increase in overdose deaths from synthetic opioids,
those that were prescribed or illicitly manufactured, such as Tramadol and Fentanyl
(CDC, 2019). The U.S. Department of Health and Human Services (HHS) in 2017
declared the opioid overdose deaths to be a public health emergency (HHS, 2017). The
term opioid crisis or opioid epidemic was used to describe this emergency. The two
terms are used interchangeably in literature and refer to the rapid rise in the
administration of prescription and nonprescription opioid drugs (Koepke et al., 2018).
This crisis is unique to the United States and is linked to the recommendation of frequent
pain evaluations, pain documentation, and treatment in the 1990s.
Despite the ongoing increase in opioid overdoses, there still remains the challenge
of managing pain without contributing to the opioid crisis. In an effort to control pain
effectively, but limit opioid usage, the use of multimodal pain management modals was
developed. Multimodal analgesia or multimodal pain management is referred to as the
use of two or more pharmacologic analgesics from different pharmacologic classes. The
medications target different pain pathways; the central nervous system and the peripheral
nervous system to achieve optimal pain relief. The goals of multimodal analgesia are to
improve the quality of analgesic effects, attain a more balanced analgesia, and decrease
or minimize the adverse effects of analgesia while minimizing opioid use (Galloway et
al., 2011).
The use of multimodal analgesia for postoperative patients was first extensively
written about in the early 1990s by Kehlet and Dahl (1993). These authors explored the
current use of unimodal treatment, and the ineffectiveness of achieving optimal pain
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relief without significant adverse effects. They theorized that since combination or
multimodal therapy (the use two or more pharmacologic analgesics from different
pharmacologic classes) was shown to be effective in less complex, small surgeries, it
should be effective for larger more complex cases. The authors recommended
multimodal or “balanced” anesthesia which would provide pain relief with a reduction in
opioids and a subsequent decrease in undesirable side effects. The authors recommended
further research to identify potentially effective combinations (Kehlet & Dahl, 1993).
The use of multimodal analgesia has been recommended by the U.S. Department
of Health and Human Services Pain Management Best Practices Interagency Task
Force. The task force recommended “procedure-specific, multimodal regimens and
therapies” (U.S Department of Health & Human Services, 2018, p.11) in the
perioperative period. These include nonopioid analgesic medications in addition to nerve
blocks. The task force found that despite these recommendations, these services are
underutilized in the perioperative setting. In a retrospective review of 799, 449 surgical
patient charts, only 65% of the patients received a dose of acetaminophen on the day of
surgery. This was compared to 97% that received an opioid on the day of surgery. The
authors further found that an average of only 34% of the patients received two or more
nonopioid analgesics the day of surgery, despite the recommendations from multiple
healthcare organizations such as the American Association of Anesthesiologists, CDC,
and the US Department of Health and Human Services that patients should receive
multimodal analgesia for optimal pain management during the perioperative period
(Ladha et al., 2016).
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Despite the many years this topic has been examined, there still remains a large
variation between providers, institutions, and regions to whether patients receive a
multimodal approach to their perioperative pain management. Some institutions and
practitioners still rely on a unimodal opioid only treatment (Ladha et al., 2016).
Practitioners must rely upon current research to guide their decisions about which
analgesics to prescribe for their patients. There is no universal guideline for multimodal
analgesia, instead there are research-based recommendations from different specialty
organizations on pain management, with many focused on chronic pain. Each
practitioner determines the appropriate treatment based upon the type of surgery, past
medical history, any genetic variants, and many other variables to prescribe a
personalized pharmacologic approach (Hsu et al., 2019). In May 2019, the Journal of
Orthopedic Trauma published its best practice recommendations for acute pain in
musculoskeletal injuries. These recommendations were developed by a panel of 15
experts in the field of orthopedics and pain management. They reviewed the literature
and based on the grading system, developed their best practice recommendations. These
recommendations were approved in December 2018 and include the use of NSAIDs,
acetaminophen, gabapentinoids, immediate-release opioids, and to consider the use of
local or regional blocks. Despite these best practice recommendations, they do state that
the final determination on pharmacological agents used should be patient personalized
pharmacologic approach (Hsu et al, 2019).
Based on the above information, it is appropriate to explore the clinical question,
“Is there a difference in postoperative opioid requirements in the first 24 inpatient hours
in adults over the age of 60 undergoing primary hip arthroplasty depending on the
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number of multimodal analgesics they received?” Next a review of the literature will be
discussed.
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Literature Review
An extensive literature review was performed using the data bases CINAHL,
Google Scholar, Medline, OVID, Cochrane, and Pub Med. The search utilized the key
words multimodal analgesia, preoperative analgesia hip arthroplasty, and preoperative
multimodal orthopedics. The search was limited to articles dated from 2015 through
2019. Recommendations for articles for literature included in a review is 2-3 years for
science and 10 years for humanities (Wolf, 2019). To expand on the available research
the date was extended to 2015. The websites that were utilized were the CDC and the US
Department of Health and Human Services. The comprehensive literature review
included opioid crisis, opioid epidemic, postoperative narcotic usage, acetaminophen
perioperative, Celebrex, Gabapentin, total hip arthroplasty, and pain pathways.
Prescription Opioid Epidemic
The World Health Organization (WHO) developed the Pain Ladder or Analgesic
Ladder in 1986. It was developed in response to guide practitioners in the treatment of
cancer pain. At that time many cancer patients were undertreated for their pain (Singh et
al., 2016). Narcotics were not administered freely, as it was believed that these patients
could never be made pain free. The WHO Pain Ladder was designed to illustrate a
stepwise approach to pain management starting with nonopioid analgesics in the
treatment of cancer pain. Although the ladder is considered by health care providers to
be outdated due to the extensive knowledge we have about pain and pain receptors, it
contributed to the philosophy of multimodal analgesia. It also helped to change the
practice of treating cancer pain. Despite the statement that it was developed to treat
cancer pain, not for management of acute or chronic pain, it has been used to help guide
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providers in the treatment of non-cancer pain. The ladder currently does not consider the
many different analgesic treatments that are currently available and relies only on
nonopioid and opioid pharmacologic agents.
Figure 1
World Health Organization Pain Ladder

Note. The World Health Organization Pain Ladder (WHO, n.d.).
Following the WHO guidelines in the 1990s, patient advocacy groups urged for
better pain control with patients. Specialty clinicians and professional groups advocated
for more aggressive pain control. Misleading information was conveyed that opioids did
not cause addiction, and in response, the amount of opioid prescriptions prescribed vastly
increased (Trasolini et al., 2018). It was discovered in 2014, that 40% of the world’s
supply of thebaine, the primary ingredient in two commonly prescribed opioids,
oxycodone and hydrocodone, was utilized in the United States (Koepka et al., 2018).
Opioid prescribing has also been found to be influenced by patient satisfaction
(Mistry et al., 2016). This is compounded by the fact that the primary survey used to
collect patient satisfaction, Press Ganey, is now being utilized for reimbursement. A
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study by Mistry et al. (2016), examined how patient’s pain control influenced their
perception of the orthopedist, nursing staff, and satisfaction with the hospital overall.
The results showed that pain control did not influence a hospital’s overall rating;
however, it did show a relationship with the patient’s opinion of their nurses, physicians,
and their general satisfaction with the hospital (Mistry et al., 2016). The authors also
reported that in a survey by Zusman (2012), 27% of physicians at that time reported their
reimbursement was partially dependent on patient satisfaction scores. Some providers
also reported that their employment was in jeopardy if they received poor patient
satisfaction scores. The authors concluded that a patient’s perception of their orthopedic
surgeons was affected by their perception of how their pain was managed
postoperatively. Those that perceived poor pain control rated their satisfaction with the
orthopedic surgeon lower than those who perceived they had received adequate pain
control.
Orthopedic surgeries are considered to be painful surgeries. According to the
American Association of Orthopedic Surgeons, orthopedic surgeons are the third highest
prescribers of opioid prescriptions (NYU Langone Health’s Department of Orthopedic
Surgery, 2019). Arthroplasty requires the orthopedist to cut deep into muscle tissue, and
bone. Historically, it required large incisions with long hospital admissions, and
assumedly more pain and discomfort. Since then, the procedure has changed, utilizing
smaller incisions with shorter hospital length of stay. Despite smaller incisions, patients
still reported substantial pain which led to a delay in initiating early physical therapy.
Orthopedists in the late 1990s were encouraged to treat the pain with narcotics,
which also contributed to increased side effects. Presently, the majority of arthroplasty
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patients are 65 years and older. These patients are at risk for falls, and postoperative
delirium along with other side effects related to opioid usage. The acknowledgement of
these factors, along with the increased knowledge of pain pathways, contributed to a
change in arthroplasty pain management (Trasolini et al., 2018).
Another contributing factor to the opioid epidemic is the availability of unused
prescription narcotics in residential homes. In a systematic review, Bicket et al. (2017)
found that many opioid pills remained untaken after orthopedic surgery. It has been
suggested that decreasing the number of narcotic pills prescribed will decrease the
availability of these opioids for illicit use and the number available for consumption,
which may decrease the risk of a patient becoming a chronic user of opioids (Hsu et al.,
2019). The CDC found that the rate of long-term opioid use was 6% one year later in
patients who consumed 1 to 5 days of opioids. This rate increased to 13.5% when
opioids were consumed for greater than eight days, and 29.9% when consumed for
greater than 30 days (Shah et al., 2017). In a randomized sample of patients, joint pain
was the most frequent reason cited for opioid being prescribed (Shah et al., 2017). To
assist with this over prescribing of opioids, 15 states in the US limit the number days an
opioid can be prescribed for an opioid naive patient for the treatment of acute pain.
Three states limit the days to just five in opioid naïve patients. Some states have
entrusted regulatory boards, such as the Department of Health or the State Board of
Medicine, to regulate rather than the state deciding opioid prescription limits (Whitmore,
& Whisenant, 2019). Next the effects of undertreated pain will be discussed.
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Effects of Undertreated Pain
Chronic undertreated pain has been associated with the development of central
sensitization (Vadivelu et al., 2014). Gabriel et al. (2019), discussed the concept of
preemptive analgesia and central sensitization. Preemptive or preventative analgesia is
defined as an analgesic given in the preoperative period prior to the incision to prevent
the development of central sensitization. With the combination of the surgical incision
and inflammatory process, preoperative pain can together contribute to the high reactivity
of the central nervous system in chronic pain. Preventative analgesia can decrease
postoperative pain levels and lessen the inflammatory response which can decrease the
risk of central sensitization.
Total joint arthroplasty surgery of the lower extremity is one of the most common
orthopedic surgeries performed. Historically, this type of surgery has been considered
painful with poorly controlled postoperative pain management. Poorly controlled
postoperative pain may lead to a delay in mobilization and postponed rehabilitation
(Chen et al., 2015). A delay in beginning rehabilitation may lead to increased length of
stay, readmissions, and increased cost of care along with decreased functional outcomes.
To treat the pain, opioids especially high dose intravenous opioids in the form of Patient
Controlled Analgesia (PCA) pumps, has become the treatment of choice (Parvizi &
Bloomfield, 2013). When patients are administered high dose opioids, they are at risk for
developing increased adverse effects, along with impaired postoperative recovery,
increased length of stay, and increased cost associated with treatment. Some of the
common reported side effects of opioids are sedation, constipation, ileus, nausea,
vomiting, urinary retention, pruritis, and respiratory depression. Respiratory depression
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in patients can lead to hypoxia which may cause additional side effects. Hypoxia,
especially in older adults can lead to delayed wound healing, increased infection,
myocardial infarction, and delirium (Parvizi & Bloomfield, 2013). When epidural
infusions have been used in place of PCA pumps with high dose opioids, these can also
encounter side effects. Some significant side effects from epidural infusions are
hypotension and urinary retention. Epidural infusions may also cause muscle weakness
that can delay postoperative physical therapy which is necessary in the recovery phase of
joint arthroplasty (Golladay et al., 2017).
One survey found that 80% of postoperative patients experience acute pain, and
86% of them rate the pain as moderate to severe (Apfelbaum et al., 2013). Postoperative
pain that is left untreated can cause reactions to many of the body’s systems. Untreated
pain effects the gastrointestinal tract by causing decreased gastric mobility. Physical
mobility is decreased in states of pain which places the patient at higher risk for
developing deep vein thrombosis, muscle spasm, and muscle wasting. It affects the
cardiovascular system by causing tachycardia, hypertension, and increased peripheral
resistance. These effects may lead to myocardial ischemia, and increased risk of
pulmonary emboli. Immobility due to pain can place the patient at risk for decreased
cough and atelectasis. Prolonged pain effects the genitourinary system by causing
urinary retention in patients. Psychologically, continual pain can lead to anxiety, fear,
helplessness, and sleep deprivation. This may also lead to increased pain. In some cases,
untreated pain may lead to a chronic pain state as result of central sensitization
(Prabhakar et al., 2014).
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Multimodal Analgesia
Multimodal analgesia is defined as the use of two or more pharmacologic
analgesics from different pharmacologic classes (Kehlet, & Dahl, 1993). This allows for
the use of less narcotic medication at a lower dosage, potentially decreasing adverse
effects. By utilizing multimodal analgesia, it allows for genetic differences in opioid
metabolism, any opioid tolerance, and pain sensitivity that a person may have
(Manworren, 2015).
The implementation of multimodal analgesia allows for the blockage of the pain
sensation through the different areas of the nociceptive and neuropathic pathway. By
administering medications that exert their action on different areas of the pain pathway
(Figure 2), it can decrease or block the neural pathway. The combinations of medications
work together to create a synergistic response to pain. When tissue damage occurs, the
pain is sensed by the nociceptors in the body. Local anesthetics such as peripheral nerve
blocks, are able to target the specific site where the damage has occurred. Neuropathic
pain arrives from damage to the nerve itself. The gabapentinoids and NMDA receptor
antagonists exert their effect on the nerve itself by decreasing the stimulation and
providing pain relief (Pitchon et al., 2018). By targeting different areas of the pain
pathway, the patient achieves more effective pain control. This in turn leads less opioid
consumption and fewer side effects (Parvizi & Bloomfield, 2013).
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Figure 2
Pain Pathway

Note. Pain pathway and locations of analgesic target treatment areas (Manworren, 2015).
Preventative analgesia requires the use of several medications in the perioperative
period. These may include the administration of N-methyl-D-aspartic acid (NMDA)
receptor antagonists, epidural analgesia, neostigmine, ketamine, gabapentin, lidocaine,
NSAIDs, and acetaminophen. All of these medications used in different combinations
have been found to provide preventative analgesia when administered using a multimodal
modal technique versus a unimodal technique. It allows for an increased length of
analgesic effect which reduces sensitization caused by prolonged exposure to pain
(Vadivelu et al., 2014).
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The American Society of Anesthesiologist Task Force on Acute Pain Management
in 2012 recommended the use of certain medications for multimodal analgesia, although
they state that every patient requires an individual approach. The list is meant as a guide
not a checkoff. The key analgesics are acetaminophen, non-steroidal anti-inflammatory
drugs (NSAIDs), gabapentinoids, opioids (short and long acting), spinal/epidural
analgesia, regional nerve blocks, and local anesthetics (Stevenson et al., 2018). In the
operating room suite, the use of ketamine, dexamethasone, magnesium, and
dextromethophan are also included in the list of multimodal analgesics (Gabriel et al.,
2019). The administration of acetaminophen and NSAIDs prior to opioids are highly
recommended and encouraged as a primary intervention whenever possible. The use of
regional analgesia (nerve blocks) has shown that by decreasing the nociceptive input it
decreases the endocrine stress response and the pro-inflammatory response. This allows
for increased tissue perfusion, decreased insulin resistance, and will improve a patient’s
coronary perfusion (Tornero et al., 2017). The most frequently administered analgesics
will be discussed.
Acetaminophen
The cornerstone analgesic is acetaminophen. It has been shown to be safe and
effective in the elderly population. It has an antipyretic, pain reducing effect, but it does
not provide any anti-inflammatory effects (Harvard Health Publishing, 2018). The exact
mechanism of action is believed to be related to a cyclooxygenase (COX) inhibition, or a
change created to the endogenous cannabinoid system. It has minimal side effects,
however there is a safety concern related to a dose dependent hepatotoxicity (Gabriel, et
al, 2019). It has a smaller safety window compared to the NSAIDs. Large doses of
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acetaminophen can lead to liver damage and possible liver failure. The recommended
maximum daily dose for a healthy adult is 4000 mg a day. Even when taken at this dose,
it may cause liver damage in some adults especially if alcohol is consumed concomitantly
(Harvard Health Publishing, 2018).
Acetaminophen is available in many forms, which makes it an easy to administer
drug. The intravenous form increases cerebrospinal fluid bioavailability, two times that
of oral, and a quicker increased blood brain barrier penetration (Politi et al., 2017). In an
experimental study, Singla et al. (2012) found that the average time to achieve maximum
concentration of intravenous (IV) acetaminophen was 15 minutes. The same dose
administered orally achieved maximum concentration levels in 45-75 minutes. The
group that received IV acetaminophen also displayed higher cerebrospinal concentration
than the group that received oral acetaminophen.
A study by Politi et al. (2017), compared IV versus oral acetaminophen as part of
their institutions multimodal perioperative pain plan in patients who underwent total joint
arthroplasty. The patients were divided, and each group received acetaminophen 1 gram
prior to surgery and a scheduled dose every six hours after. Acetaminophen was
administered for 24 hours. The visual analog scale (VAS) and the number of narcotics
administered, was collected every 4 hours. The authors found that the 24-hour dosage of
narcotics administered was equal in both groups, along with their 24-hour VAS scores.
The only difference noted was in the 0-4 hour interval, where the VAS score was higher
by one point in the group that received the oral acetaminophen, however the actual
narcotic dosage administered in that time showed no significant difference. An
approximate cost of 1gram IV acetaminophen was $33.05 versus $0.05 for 1 gram of oral
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acetaminophen. Due to the cost, and lack of significant opioid consumption difference,
the authors recommend oral acetaminophen versus IV whenever possible.
In a randomized blinded study (Westrich et al., 2019), IV acetaminophen was
compared to oral acetaminophen in patients undergoing total hip arthroplasty. The
groups either received 1 gram of IV acetaminophen with oral placebo, or 1gram oral
acetaminophen with IV placebo 30 minutes after entering the recovery room. They
continued with this administration combination every six hours after the first dose until
three days postoperative, or until discharge if that was earlier than three days. In this
study, the patients were not prescribed any standing opioid orders. All opioids were
ordered on an as needed basis. The authors found that there were no significant
differences in pain scores, opioid side effects, or opioid administration between the two
groups (Westrich et al., 2019).
In a randomized double-blind study, the administration of IV or oral
acetaminophen was evaluated as an adjunct to a multimodal analgesia plan for patients
undergoing total knee arthroplasty. The patients were divided into three groups; a
placebo group, a group that received 1 gram of IV acetaminophen in the recovery room,
and a final group that received 1 gram of oral acetaminophen in the recovery room. The
authors evaluated the pain scores, and narcotic consumption for the first 24 hours
amongst the three groups. In this study, investigators observed no significant difference
amongst pain levels or narcotic consumption amongst the groups. The authors concluded
that other studies had analyzed administration in the preoperative period and continued
the administration of acetaminophen throughout the first 24 hours. In this study it was a
onetime administration in the recovery room. The investigators concluded that
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acetaminophen administered preoperatively may affect the nociceptive receptors
differently, which may bring about better analgesic effects (O’Neal et al., 2017).
Anti-inflammatory medications
Nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX 2)
inhibitors provide an antipyretic and analgesic effect. They also have an antiinflammatory effect in which they inhibit prostaglandin production. This inhibitory
effect can last through the intraoperative period into the postoperative recovery period.
They block pain receptors peripherally in the ascending pain pathway, and centrally in
the spinal dorsal horn. There they stop prostaglandin production via COX 2. They also
stimulate the areas that encompass the descending inhibitory pain cascade. NSAIDs
block both COX 1 and COX 2, whereas celecoxib and rofecoxib are inhibitors of COX 2
only (Gupta & Bah, 2016).
There are concerns regarding potential adverse effects of NSAIDs. Their use is
limited in the elderly and patients who have preexisting renal disease. Risks associated
with the NSAIDs are cardiovascular, gastrointestinal, and renal. NSAIDs have
traditionally been held prior to surgical procedures due to the risk of increased bleeding.
Despite some reported risks, studies have shown no increased risk in cardiovascular
incidents or bleeding when given in the acute postoperative period (Gupta & Bah, 2016).
The side effects from NSAIDs are due to prostaglandin synthesis. COX 2 inhibitors have
less effect on the coagulation cascade, which make them favorable in the perioperative
period for most surgeries (Stevenson et al., 2018). In patients undergoing colonic
resections, the administration of NSAIDs and COX-2 inhibitors should be given with
caution. There have been a few studies that have shown a significant increase in
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anastomotic leak when NSAIDs were given. This rate decreased when the medications
were discontinued (Gupta & Bah, 2016).
In a study by Chen et al. (2015), celecoxib was examined in elderly patients
undergoing total hip arthroplasty. Patients were given a placebo, or a 400 mg dose of
celecoxib one hour preoperatively. Following the preoperative administration, the
patients were then given the placebo, or 200 mg of celecoxib every 12 hours for five
days. The results showed that despite no statistical difference in VAS score, the group
that received celecoxib was able to ambulate earlier than the patients who received the
placebo. The celecoxib group consumed significantly less opioids than the control group
did. There also was no statistical difference in intraoperative or post-operative blood loss
between the two groups (Chen et al., 2015).
A comparison study by Onda et al. (2016), examined the effect on postoperative
pain after administering either celecoxib, loxoprofen, or acetaminophen. Patients
enrolled underwent arthroscopic knee surgery with removal of an internal fixator. The
patients received either celecoxib 400 mg for the first dose (200 mg the following doses),
loxoprofen 60 mg, or acetaminophen 600 mg in the postoperative period with the first
dose given three hours after completion of surgery. Subsequently, the patients continued
on the medication for 48 hours. The VAS at rest for all groups remained equal until the
24-hour mark in which the celecoxib and loxoprofen groups were significantly lower than
the group that received acetaminophen. This result was also demonstrated at the 48-hour
mark. When compared to the VAS with movement, the group that received the celecoxib
had lower scores at all post medication time points. The researchers examined the
patient’s appraisal of their pain treatment outcome. Each group rated their pain

19

management as excellent (no pain following treatment), good (significant improvement
following treatment), acceptable (somewhat improved following treatment), and poor (no
change or worse since treatment) 24 hours postoperative and 48 hours postoperative. The
results showed no statistical difference in results between all groups at 24 hours
postoperative. At 48 hours, the group that received celecoxib expressed greater
satisfaction in their pain treatment compared to the other two groups. In the celecoxib
group 47.2% responded that they received excellent results to their pain treatment (Onda
et al., 2016).
Ketorolac is another NSAID that has antipyretic, analgesic, and anti-inflammatory
effects. Its action inhibits the COX1 and COX2 enzymes. It is available in oral, IV, and
intranasal (IN) forms. The drug was approved in 2010 for moderate to moderately severe
pain for up to five days. The IN form was discovered to have the potency of morphine.
Ketorolac IN is expensive. The price for five days of treatment was $1000 (Pitchon et
al., 2018).
Ketorolac is similar to other NSAIDs in the concern for delayed bone healing
(Hassan & Karlock, 2019). A study by Donohue et al. (2016), examined the healing rates
of tibial and femoral fractures when ketorolac was administered. This retrospective chart
review examined each fracture type divided into two groups. One group received
ketorolac in the first 24 hours after the fracture, and the other group did not. Both groups
displayed similar healing times, and similar rates of bone nonunion. In the group that
received the ketorolac, only patients with a current history of smoking had delayed bone
healing (Donohue, 2016).
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Gabapentinoids
The gabapentinoids include gabapentin and pregabalin. They are classified as
anticonvulsant medications exerting an effect on the alpha2-delta unit in the calcium
channels in the central nervous system. They decrease the discharge of neurotransmitters
in the excitatory pathways (Gabriel et al., 2019). This inhibits pain transmission along
with central sensitization (Schmidt et al., 2013). Adverse effects of gabapentinoids
include sedation and respiratory depression (Gabriel et al., 2019). There are a multitude
of studies using gabapentinoids as part of a multimodal analgesia regimen in the
perioperative period. The studies all vary with timing, dosage, and medication; there are
currently no specific recommendations for prescribing.
In a systematic review with meta-analysis by Fabritius et al. (2017), they
examined 74 Randomized Controlled Trials (RCTs) and assessed the harm and benefit in
the administration of gabapentin in procedure specific surgeries. The surgeries that were
included were cholecystectomy, mastectomy, hysterectomy, thoracic surgery, spinal
surgery, and orthopedic arthroplasty. These specific surgeries were chosen to represent a
diverse patient population with various surgical procedures. A cholecystectomy is
perceived as a minor surgical procedure that is often done as an outpatient surgery.
Hysterectomy and mastectomy usually require a short stay and are considered to be
associated with moderate amounts of pain. Thoracic surgery is associated with large
amounts of pain and may require Intensive Care Unit (ICU) admission after the surgical
procedure. The authors included orthopedic arthroplasty and spinal surgery to represent
what they determined as surgical patients that preoperatively may represent patients with
chronic pain. There was a total of 74 trials included in the RCT, however only eight
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trials were considered to have an overall low risk of bias. This included one trial from
the cholecystectomy group, two trials from the hysterectomy group, two trials from the
thoracic surgery group, and three trials from the orthopedic arthroplasty group. None of
the trials done on patients having a mastectomy were considered low bias. The
gabapentin dosages ranged from 300 mg to 1800 mg. Morphine consumption at the 24hour mark was compared in 51 of the trials, but of those trials only seven were
considered low bias. The authors found that in all six surgeries examined, there was a
decrease in morphine consumption when gabapentin was administered. However, the
authors did not specify whether the medication was administered preoperative or
postoperative. They found that the trials all contained poorly documented serious
adverse effects, with only half the trials reporting any adverse effects. The lack of
adequate documentation led the authors of the systematic review to view the results as
inconclusive.
A meta-analysis of randomized controlled trials by Hu et al. (2018), examined the
effects of a single dose of pregabalin and gabapentin preoperative in relation to
postoperative opioid consumption. In the 79 trials examined, they found the
administration time varied from one hour before surgery to greater than one hour after
surgery. The type of anesthesia administered also varied from spinal anesthesia to
general anesthesia. The dose of pregabalin varied from 150 mg to 300 mg, and the dose
of gabapentin varied from 300 mg to 1200 mg. The authors found that as the dose of
pregabalin or gabapentin increased, the number of opioids consumed decreased. The
greatest effect was observed with gabapentin 1200 mg followed by pregabalin 300 mg.
The study noted that high doses of pregabalin increased the rate of dizziness, but also
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decreased the rate of postoperative nausea and vomiting. High doses of gabapentin, 1200
mg, were associated with increased rates of postoperative nausea and vomiting (Hu et al.,
2018).
In a systematic review with meta-analysis, the authors examined the efficacy of
administration of gabapentin or pregabalin in the preoperative period in patients
undergoing total hip arthroplasty. The dosage of gabapentin ranged from 150 mg to 1200
mg per day. In this study they found that the cumulative morphine dose was lower the
first 24 and 48 hours on the pregabalin/gabapentin group, however there was no
significant difference in their pain scores (Mao et al., 2016). Furthermore, a metaanalysis by Han et al. (2016), examined randomized controlled trials on total knee
arthroplasty patients and the use of postoperative gabapentin. They evaluated narcotic
consumption at 12 hours, 24 hours, and 48 hours postoperatively along with the patient’s
visual analog scale (VAS). They reviewed six studies which included 420 patients. The
studies examined gabapentin versus a placebo preoperative, and gabapentin 300 mg, 600
mg, and 900 mg postoperative versus a placebo. The results showed a significant
reduction in opioid consumption in the patients that received gabapentin in all of the
hours examined. They did not see any significant difference in VAS scores between the
groups during the time frame despite the reduction in opioid consumption.
In studies that compare the efficacy of gabapentin versus pregabalin, pregabalin
was found to achieve longer postoperative pain-free periods than gabapentin. However,
pregabalin can increase respiratory depression, so caution must be used in patients with
obstructive sleep apnea (OSA) and the elderly population. Currently, only gabapentin is
available in generic form, so there remains a cost difference between the two medications
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which could account for the limited studies evaluating the medications (Pitchon et al,
2018).
NMDA receptor antagonist
Ketamine is a N-methyl-D-aspartate (NMDA) receptor antagonist that was
created in the 1960s to be utilized as a general anesthetic. It provides its analgesic effect
via the NMDA receptors. At subanesthetic dosages, it helps to control central
sensitization and decreases opioid induced hyperalgesia. This is useful because it
decreases opioid tolerance and is effective in treating patients with an opioid tolerance
(Gabriel et al., 2019). Some animal studies have shown that NMDA antagonists can
possibly reverse opioid induced tolerance along with the prevention of developing an
opioid tolerance (Pitchon et al., 2018). Due to its effectiveness with opioid tolerant
patients, it is now becoming part of the treatment plan in many hospitals for the treatment
of pain in individuals who are opioid tolerant (Gabriel et al., 2019).
Ketamine use has been limited outside the operating room due to its side effects.
It can cause psychomimetic effects that include hallucinations, vivid dreams, dissociative
feelings, diplopia, blurred vision, sedation, and dysphoria. Most psychomimetic
symptoms resolve immediately after the medication is discontinued (Gabriel et al., 2019).
In an article by Schwenk et al. (2016), they found that 95% of adverse effects went away
with the discontinuation of the ketamine infusion. Ketamine does not cause respiratory
depression and has been shown to provide some postoperative analgesia and decrease
opioid consumption. It is recommended that ketamine be used cautiously in the elderly
population (Pitchon et al., 2018).
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The use of ketamine in spinal surgery has been well studied, but the use of
ketamine in joint arthroplasty has not been examined as extensively. In a study by
Cengiz et al. (2014), they examined the use of low-dose ketamine infusion during total
knee arthroplasty surgery. In the study, which received ethical approval from the Clinic
Research Ethical Community of The Turkish Ministry of Health, one group was
administered a ketamine infusion, and the other group a placebo saline infusion. The
time to first request for pain medication was longer in the group that received ketamine.
They also found that morphine consumption at postoperative hours 1, 3, 6, 12, and 24
was also lower in the ketamine group. The amount of morphine administered decreased
by 45%. The length of time spent in the recovery room was increased in the group that
received ketamine versus the saline infusion group. Patients’ VAS all decreased in the
group that received the ketamine infusion. However, the authors found no statistically
significant difference between groups regarding adverse effects.
Peripheral nerve blocks
The use of regional blocks and local anesthetic injections have increased in the
last few years with the addition of ultrasound to guide the injections (Gabriel et al.,
2019). Multiple studies show decrease length of stay (LOS) and decrease opioid
consumption in patients who receive regional blocks. The concern regarding blocks is
the risk for infection or bleeding. Some site-specific risks are pneumothorax for brachial
plexus and truncal blocks, quadricep weakness and falls from femoral nerve blocks, and
peripheral nerve injury (Gabriel et al., 2019).
In a study by Ellis et al. (2018), patients undergoing total knee arthroplasty were
evaluated before and after implementation of a clinical pathway that incorporated femoral
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nerve blocks, adductor canal blocks, and multimodal oral analgesic protocols. The
clinical pathway was implemented and evaluated in the three phases. The first phase
patients received only spinal anesthesia and a femoral nerve block. The second phase
included spinal anesthesia, but the femoral nerve block was replaced by an adductor canal
block. In the final phase, patients received spinal anesthesia, the adductor canal block
and an oral multimodal analgesic protocol that was the same for all patients.
The researchers found that length of stay (LOS) was decreased in the groups
receiving the adductor block versus the femoral block, and the group that received the
adductor block with the oral multimodal analgesics had the shortest length of stay by one
day. The group in phase one, two, and three average LOS were 3.89, 3.26, and 2.12 days
respectively. The group that received the femoral block, phase one, rated on average
higher pain levels than those that received the adductor block. The difference in pain
scores between the two adductor groups was deemed not clinically significant (Ellis et
al., 2018).
Total opioid consumption between the three groups revealed that the group that
received the femoral block required more narcotics than the groups receiving adductor
canal blocks. There was only a slight decrease in narcotic consumption for the group that
received the oral multimodal medications which was not statistically significant. None of
the groups received a standing postoperative acetaminophen order. When the doses
administered were compared, there was significantly less administration of opioids in the
two adductor canal groups compared to the femoral block group. There was no
significant difference between the two adductor canal groups. Femoral blocks contribute
to greater postoperative quadricep weakness as compared to adductor blocks. In this
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study, there were no patient falls reported in the adductor canal groups. The group that
received the femoral block sustained five falls, which was 5% of that study group. There
was significant decrease in antiemetic administration in the adductor canal groups as
compared to the femoral block group. There were no other statistical differences in
adverse effects between all three groups (Ellis et al., 2018).
In a Cochrane Systematic review by Chan et al. (2014), the effect of femoral
nerve blocks (FNB) in total knee arthroplasty in postoperative pain were evaluated. They
first examined pain levels at rest and with movement in patients comparing FNB with a
PCA (Patient Controlled Analgesia), FNB without a PCA, and PCA only. They found
that patients reported less pain when an FNB was performed. It also resulted in less
opioid consumption, and consequently less postoperative side effects such as nausea,
vomiting, and sedation. When FNB was compared with an epidural block, patients
reported greater satisfaction with an FNB. The patients who received a femoral block
also had decreased opioid consumption in the first 24 hours. The authors found only a
single study that compared FNB and oral analgesia. In this study the FNB group had
significantly less pain than the oral analgesia group. Finally, investigators compared a
continuous FNB to a single dose FNB. The continuous FNB offered greater analgesia
and led to lower opioid consumption in the first 24 hours (Chan et al., 2014).
Guidelines for Analgesics in Orthopedic Patients
Guideline and recommendations are written to provide patients with the most
current up to date treatment and best outcomes. Such guidelines offer evidence-based
practice recommendations that may come from government agencies such as the National
Institute for Health, or specialty professional organizations such as the Orthopedic
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Trauma Association. Some guidelines are written in response to certain situations or
events. The Orthopedic Trauma Association developed pain management guidelines for
acute musculoskeletal injuries in response to the opioid epidemic. Studies have found
orthopedic surgeons represent only 2.5% of all physicians but prescribe 7.7% of narcotic
prescriptions. In a study by Hooten et al. (2015), researchers found that 21% of all
patients who receive their initial prescription for pain medication will continue to receive
additional prescriptions, and 6% of those patients will become chronic users. In addition,
the authors also observed that many opioids prescribed after orthopedic surgery are
unused, possibly contributing to the increased availability of opioids in the public. The
organization felt the need to begin changing prescription habits of orthopedic physicians
(Hsu et al., 2019).
In 2012 the American Society of Anesthesiologists Task Force on Acute Pain
Management published evidence-based guidelines for the treatment of pain in the
perioperative period. They recommended the use of multimodal pain management for
patients and the consideration of regional blocks whenever possible. They further
recommended the use of COX2, NSAIDs, or acetaminophen as a scheduled, not as
needed, medication unless there was a contraindication (American Society of
Anesthesiologists, 2012). In 2015, the American Pain Society published
recommendations for management of postoperative pain with input from the American
Society of Anesthesiologists. The guidelines recommend the use of multimodal
perioperative analgesia, with the recommendation that acetaminophen and NSAIDs are
prescribed whenever not contraindicated. They further recommended the administration
of celecoxib, and a gabapentinoid in the preoperative period. The use of oral medication
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was recommended over intravenous medication, along with the use of nerve blocks
whenever possible (Chou et al., 2016). A study by Ladha et al. (2016), suggests that the
administration of multimodal analgesia was dependent on certain factors. Researchers
hypothesized from the data that these were the culture of the hospital and the physicians'
preference. Their results indicated that multimodal analgesia had not been universally
adapted. The authors did not examine reasons for the low usage but suggest that the
variation in evidence to support multimodal anesthesia across different surgical
procedures may contribute to the reluctance to implement the recommendations. They
also felt that the number of providers each patient sees in the perioperative period can
make it difficult to determine who is the responsible provider for prescribing
perioperative analgesics (Ladha et al., 2016).
In May of 2019 the Orthopedic Trauma Association posted guidelines for pain
management in acute musculoskeletal injuries (Hsu et al., 2019). The 15-member panel
consisted of experts in the field of orthopedic trauma, pain management, or both. The
goal was to produce guidelines and recommendations to treat acute pain in patients that
sustained musculoskeletal injury. It was also created to be utilized by other orthopedic
practices and specialties. The research was reviewed and the recommendations they
provided received a grade based on the Grading of Recommendations Assessment,
Development, and Evaluation Working Group (Grade, n.d.). This method is used to
grade the quality of the evidence, which is based upon the design of the study, the actual
number of studies done, the sample size in each study, and if the results remain consistent
amongst the studies. The studies are graded as strong (benefits outweigh potential harm)
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or as conditional (benefits do not outweigh potential harm). The evidence is further
classified as having low, moderate, or high- quality evidence (Hsu et al., 2019).
The panel recommended the use of multimodal analgesia versus unimodal
analgesia for pain control as a strong recommendation with moderate quality evidence.
They referred to multimodal analgesia as a balanced analgesia, incorporating the use of
multiple analgesics in addition to nonpharmacologic interventions that would affect the
central or peripheral nervous system along the pain pathway. The use of periarticular
injections as an adjunct was strongly recommended with moderate quality of evidence.
The panel recommended prescribing the lowest dose of opioid for the shortest amount of
time as strong with high-quality evidence. The recommendation to avoid long-acting
opioids for acute injury is strongly recommended with low quality evidence. NSAIDs in
patients with fractures, operative or nonoperative, is strongly recommended based on low
quality evidence. The use of NSAIDs has been contraindicated in the past due to the
concerns with bone healing. The panel found the evidence conflicting but based on
beneficial results from use of NSAIDs to relieve musculoskeletal pain, withholding it
from the multimodal plan may be more detrimental to the patient’s pain relief than taking
the medication (Hsu et al., 2019).
For the operative treatment of fractures, the panel recommends local or regional
block anesthesia in the multimodal pain control plan as strong recommendation with high
quality evidence. The panel also provided recommendations for pain relief after
musculoskeletal injury using multimodal medications that include NSAIDs,
acetaminophen, gabapentinoids, and immediate release opioids (Hsu et al., 2019).
Whereas, the recommendations from the panel after a major musculoskeletal injury
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procedure, such as fixation of a long bone fracture, are the following for postoperative
inpatient analgesia: ketorolac 15 mg IV for five doses followed by ibuprofen every eight
hours, gabapentin 100 mg TID, acetaminophen 500 mg every 12 hours, and oxycodone
every four to six hours as needed for pain. The recommendations include
hydromorphone 1 mg IV every three hours prn for severe breakthrough pain. The panel
also strongly recommends psychosocial interventions for patients who experience greater
than expected or persistent pain. They also state that the use of these guidelines is not
intended for the management of chronic pain (Hsu et al., 2019).
A recent retrospective study examined sleep apnea patients who received
nonopioid analgesia (Cozowicz et al., 2019). The authors reviewed 181,182 patients’
chart who underwent total hip or knee arthroplasty. Patient medical records were
examined to determine if nonopioid analgesic modes were utilized the day of surgery or
the day after. The information was then categorized as one, two, or more than two nonopioids administered. The non-opioids were described as peripheral nerve blocks,
paracetamol or acetaminophen, steroids, gabapentin or pregabalin, ketamine, NSAIDs, or
COX 2 inhibitors. Administration of a COX 2 inhibitor was found to decrease opioid use
by 12.6%, and the use of an NSAID decreased opioid consumption by 11%. The
researchers found that with the increase number of non-analgesic modes given, there was
a stepwise decrease in opioid dose and postoperative complications. The largest reduction
in postoperative complications were decreased postoperative mechanical ventilation and
postoperative admission to a critical care unit. The decrease in the odds for mechanical
ventilation and critical care admissions also stepwise decreased with the administration of
two or more non-opioid analgesics. The chance for gastrointestinal complications
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decreased by up to 35% with administration of two or more non-opioid analgesics. The
results showed that the patients who displayed largest opioid reduction, were those who
received COX 2 inhibitors or NSAIDs. The study also found a stepwise decrease in
LOS associated with increase in multimodal administration. The LOS decreased by up to
11.8% with the use of multimodal analgesia (Cozowicz et al., 2019).
Barriers to Prescription Guideline Adherence
A qualitative study was performed using the Theory of Planned Behavior to
explore the barriers to the implementation of guideline prescribing recommendations.
This was a small study of general practitioners in primary care. Seven themes emerged
from the interviews. First, physicians questioned the credibility of the evidence. If they
felt the evidence was weak, irrelevant, or unconvincing they would conclude that there
was not credible evidence. They also were concerned with how rapidly the guideline
may change, and frequent changes in practice may make patients skeptical of the care
they were receiving (Rashidian et al., 2008). Second, if the guidelines were written by a
source that was deemed credible, such as national guidelines, they were more apt to
implement them. The sources that were perceived as not credible were deemed as low
quality and low credibility and were not apt to be followed. The physicians cited sources
such as pharmaceutical companies and consultants as untrustworthy (Rashidian et al.,
2008).
The third theme recognized was the presentation of the guidelines. If the
guidelines were complex and complicated they were less likely to be followed.
Complicated guidelines were felt to be confusing and difficult to understand. The
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guidelines that were deemed strong and simple were more apt to be followed, although
not all practitioners agreed upon what was perceived as simple (Rashidian et al., 2008).
The fourth theme to emerge was influential people. The physicians stated that
colleagues, and local consultants influenced their treatment guidelines. They described
coming to shared agreements regarding patient care in meetings. These decisions may or
may not be in accordance with current guidelines. Patient preference also influenced
treatment. The perceived pressure from patients as an influencing factor in what was
prescribed in some cases (Rashidian et al., 2008).
The fifth theme identified was organizational barriers. The physicians described
the inability to obtain access to certain resources. Some examples given were access to
equipment, and support in implementing electronic databases. They reported time to
implement as a barrier to compliance. The time requirement to disseminate the
information and train the staff was perceived as difficult due to limitations in work time.
These time constraints inhibited their ability to implement new guidelines. Some
physicians also cited cost as a factor. If some of the new guidelines implemented new
medications that were costly, that may deter the physician from following the guidelines
or recommendations. They state they are under scrutiny to adhere to a prescription
budget, and the cost of some newer medications exceed that budget (Rashidian et al.,
2008).
The sixth common barrier was disease characteristics. The group of physicians
evaluated were primary care physicians, and they felt that diseases that displayed
complex characteristics, that guidelines were not helpful. The physicians had limited
roles in treating these patients, and they had concerns in using guidelines in conditions

33

that they considered difficult to diagnose. In other conditions that they considered
simple, they believed a recommendation or piece of evidence may prove to be more
beneficial than guidelines (Rashidian et al., 2008).
The final theme that emerged was implementation strategies. The physicians
were reluctant to follow guidelines when it was handed to them with the expectation that
they must follow it. They also reported concern, that if some guidelines are
misinterpreted adverse outcomes may occur. The feeling of not being involved in the
creation of the guideline was also perceived as a barrier to adherence. Some physicians
felt that if they had more local involvement in the writing and implementation, they
would be more willing to incorporate the guidelines. (Rashidian et al., 2008).
Likewise, a systematic review by Slade et al. (2016), examined barriers to clinical
guidelines for management of low back pain by primary care clinicians. A total of 17
articles met criteria for review. They found three consistent emerging themes. The first
was that the clinicians relied mostly on their past experiences and judgement over clinical
guidelines. They also reported that current practice among peers was more important
than what the guidelines recommended. The second theme was to maintain the patientclinician relationship. They acknowledged that patient’s expectations may not be in line
with current recommendations, and that if they did not follow through on the patient’s
requests that their clinical ability may be doubted. The final theme noted was time.
Clinicians felt that they were overwhelmed with the number of guidelines, and did not
have enough time to read, and incorporate them into their practice. They also cited lack
of access or waiting times for other specialists or services such as physical therapists as a
factor for providing treatment not recommended in the guidelines. The overuse of
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diagnostic imaging was a common theme. Patients request imaging, even if diagnostic
imaging is not recommended in the guidelines. Delays in the ability to have patients seen
by specialists prompted the clinicians to get diagnostic imaging because it was faster
rather than follow current recommendations.
In summary, studies have shown mixed results about which types of analgesics
provide optimal pain relief while decreasing opioid consumption. However, studies do
suggest that applying a multimodal analgesic approach provides better pain relief by
targeting different areas on the pain pathway (Golladay et al., 2017). Evidence does
support that untreated pain can cause physical and psychological distress and may
provide a role in chronic pain syndromes (Prabhakar et al., 2014). In 2019, the
Orthopedic Trauma Association published guidelines to help provide evidence-based
recommendations for pain management in patients with acute musculoskeletal injury.
This was in response to the increase publicity and recognition of the opioid epidemic.
They recognized that several professional organizations and government organizations
had already released guidelines for safe opioid prescribing, although they mainly
concentrated on chronic pain and not acute pain. The goal was to supply physicians with
best practice recommendations, but they emphasized that implementation should be
individualized and administered by physician discretion (Hsu et al., 2019).
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Theoretical Framework
Pain is a symptom that has a cascading effect on multiple systems in the body.
Pain may originate from many different sources. The Theory of Unpleasant Symptoms
(TOUS) is based on the premise that multiple symptoms can occur together (Lenz &
Pugh, 2013). The theory was created by four nurse researchers who began by
independently researching the character and experience of different symptoms. Their
shared perspectives and close proximity to each other allowed for a collaboration of
information on their research. They found that there were related concepts and
commonalities with their independent findings on fatigue during labor and delivery,
which led to the development of a framework to explain fatigue in childbearing
situations. The second partnership was during the discussion of fatigue with chronic
obstructive pulmonary disease and asthma. During their discussions they realized there
were a number of similarities between the two symptoms. This unexpected spontaneous
discovery led the researchers to collaborate to develop a middle range theory that was
clinically based (Lenz & Pugh, 2013).
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Figure 3
Theory of Unpleasant Symptoms

Note. The diagram of the middle range Theory of Unpleasant Symptoms (Lenz et al.,
1997).
The TOUS is founded on three major concepts (Figure 3). The concepts are
symptoms, influencing factors, and performance factors. The first concept symptoms is
considered the central concept. Symptoms may be defined as a change in daily
functioning which is reported by patients. The change that occurs may or may not be
unpleasant and may or may not be an observable sign. Only the individual experiencing
the change can truly measure it. The TOUS maintains that these symptoms can occur
individually, in isolation, or with other symptoms (Lenz & Pugh, 2013). In patients
undergoing total hip arthroplasty, they are required to withhold any NSAIDs for a
minimum of two weeks prior to surgery. Many of these patients have been on medication
for years to help manage their arthritic pain. These patients arrive in the preoperative
area and report significant pain. This increase in pain due to discontinuation of their
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medication may limit their ability to perform tasks that they were able to perform while
on the medication. This along with the years of physical decline from their osteoarthritis
is the “symptom” in the TOUS theory. The progressive decline through the years has
caused many changes in their daily function.
The second major concept in TOUS is influencing factors. Influencing factors are
elements that can change the way a symptom is experienced. Three factors have been
identified that are considered most relevant. They are psychological, physiological, and
situational factors. The combination of all three factors can result in a more intense
symptom than just one or two of them combined. How a symptom is experienced is
relevant to these specific factors, and how influential each factor is can be variable
between individuals (Lenz & Pugh, 2013). Hip arthroplasty is an elective surgery that is
performed when a person can no longer perform their activities of daily (ADLs) due to
pain and/or limitations in the joint. This may be due to collapse of the joint space or
significant arthritic changes. Common physiological changes may be that a person is no
longer able to walk upstairs or can no longer walk a distance of even five feet without
severe pain. These changes may also include falls due to the collapse of the hip joint.
The inability to be able to independently care for oneself can have significant
psychological effects on a person, especially those that may be alone, or have limited
assistance at home. Although this can be an extremely limiting situation for a patient, by
medical standards the surgery itself is still classified as elective surgery. This means a
patient can wait upwards of four months before they are able to have surgery. This wait
period can cause increase stress on the patient prior to surgery. The loss of independence
with the possible isolation from friends and family, and the waiting for surgery
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contributes to the influencing factors that change a way an event is perceived or
experienced.
The final major concept is performance, which is the outcome concept of TOUS.
The symptoms a person experiences can influence how a person is able to function or
perform. There is an after effect to the symptoms that were experienced. This outcome
may or may not affect the person’s quality of life. The TOUS does not address quality of
life as an outcome, but merely states that it is a feedback loop that has a reciprocal
influence on the symptoms group (Lenz & Pugh, 2013). The preoperative patient for total
hip arthroplasty in some cases has waited months in discomfort with limited mobility.
They are stressed, and anxious prior to arrival. Their success for an optimal recovery is
dependent on their ability to actively engage in early/ immediate postoperative
rehabilitation. By providing adequate preoperative education and medication, extreme
pain and central sensitization can be prevented (Trasolini et al., 2018)
Patients who reported low postoperative pain levels have been shown to have a
decreased morbidity rate and an improved postoperative recovery (Valencia & Leopo,
2017). The ability to decrease anxiety and pain in the preoperative area may decrease
postoperative anxiety and medication usage (Daltroy et al., 1998). The implementation
of Enhanced Recovery Pathways (ERP) in patients undergoing total hip arthroplasty,
which includes preoperative analgesia and early mobilization, has resulted in shorter LOS
and satisfactory pain control (Ibrahim et al., 2013).
A patient undergoing a total hip arthroplasty who is anxious and in pain
preoperative and postoperative may not be able to begin the necessary postoperative
physical therapy immediately. Delay in activity predisposes patients to adverse

39

physiological effects such as bed sores, deep vein thrombosis, myopathy, decreased
respiratory function, and pneumonia (Soffin & YaDeau, 2016). Whereas the patient who
has less pain (symptoms), may be more willing to partake in therapy. Early mobilization
in hip arthroplasty has been shown to decrease length of stay and increase patient
satisfaction (Chen et al. 2012).
Patients in the perioperative period experience many unpleasant symptoms.
These patients experience pain from their osteoarthritis, phlebotomy, and intravenous
access necessary in the preoperative period. Many patients also experience a certain
degree of anxiety, pain, fear, and apprehension prior to surgery. These symptoms can be
placed in the Theory of Unpleasant Symptoms diagram (Figure 3), which illustrates how
all of these combined can affect the outcome, or pain experience in the postoperative
period.
In an article by Nguyen et al. (2017), the authors applied the Theory of
Unpleasant Symptoms to the educational training of student nurse anesthetists. They
explained that TOUS helps the students recognize the need to examine many aspects of a
patient’s symptoms. Nurses must scrutinize information relayed to them by patients and
assess how some symptoms may influence other factors. Pain, anxiety, fear, and
emotional stress are all unpleasant symptoms in the preoperative period. The student
must examine these and provide measures to relieve the unpleasant symptoms which
result in improved outcomes. During the postoperative period there may be increased
pain, which if left untreated can cause physiological and psychological effects. The
knowledge to apply multimodal analgesics can aid in alleviating some of the unpleasant
symptoms. Another unpleasant symptom in the perioperative period is hypothermia.
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Patients lose heat quickly as a result of the cold operating room environment and
anesthetics. The unpleasant symptom of being cold may lead to shivering and shaking.
Application of warm blankets and warm intravenous fluids can help to maintain body
temperature and provide comfort.
The final common unpleasant symptom in postoperative patients in nausea and
vomiting. By assessing patients adequately in the preoperative period, appropriate
preventative medications can be administered to relieve the unpleasant symptom. Risk
factors such as prior history of postoperative nausea and vomiting, motion sickness, being
female, and being a nonsmoker can place a patient at higher risk for nausea and vomiting
after surgery. When identified as being at higher risk, appropriate anesthetic agents and
medications can be administered to reduce the unpleasant side effect. By recognizing and
understanding how all these unpleasant symptoms affect each other, the student nurse
anesthetist is able to ease symptoms and provide optimal outcomes (Nguyen et al.,2017).
The variables in the TOUS model align well with the overall aim of the proposed study
that will exam pain management using a multimodal treatment approach with surgical
adults who underwent total hip arthroplasty.

41

Method
Purpose
The purpose of this project was to identify if there is a difference in postoperative
opioid requirements in the first 24 inpatient hours in adults over the age of 60 years
undergoing primary hip arthroplasty depending on the number of multimodal
perioperative analgesics they received. The age of 60 was chosen based upon the
findings from the American Joint Replacement Registry 2016 annual report that the
median age of hip replacement in 2015 was 65.4 years old. The literature utilized for the
review described the median ages of 62 to 68 years old for total hip arthroplasty.
However, to increase the probability of obtaining an adequate sample size, patients’
charts with a documented age of 60 years and older were selected for this study.
Design
The design was a retrospective chart review of patients who underwent primary
total hip arthroscopy. Charts were categorized into five classes based on the multimodal
analgesics received. Postoperative narcotic medication usage was converted to morphine
equivalents to accurately examine total usage. Preoperative pain scores were compared
to postoperative pain scores and compared against the different multimodal analgesia
administered. Many patients arrive to the preoperative area with some degree of pain.
By obtaining the preoperative pain level it can be determined if there was a reduction in
overall pain level related to the number of multimodal analgesics administered.
Sample
The sample included 200 charts of adult patients who underwent elective primary
total hip arthroplasty that met the inclusion and exclusion criteria. Sample size was

42

determined by the estimate of patients who underwent total hip arthroplasty over a threemonth period at the clinical site and was elevated to provide an increased probability of
detecting significant differences in the groups. Chart review included documented male
and female patients age 60 and over with intact cognition. Exclusion criteria included
patients with previous partial or total hip replacement on the same joint, currently on
opioid medications for chronic pain (oxycodone, tramadol, morphine, oxycontin, or
fentanyl), those with documented allergies to acetaminophen, and NSAIDs and
acetaminophen, but an allergy or contraindication to NSAIDs alone did not exclude the
patient. Further exclusions were patients with past medical history (PMH) of renal
failure, liver disease, hemophilia, currently on suboxone or methadone, any documented
alcohol or substance abuse disorder, and those with a diagnosis of neuropathic pain.
Site
The study site was the perioperative services and inpatient adult floors at a large
tertiary care facility located in Rhode Island. The hospital is a 719 bed, non-profit, level
1 Trauma Center which is the primary teaching hospital for Warren Albert Medical
School of Brown University in Providence Rhode Island.
Ethical Considerations
There were no ethical concerns identified. The medical charts reviewed were for
discharged patients, and no charts of deceased patients were reviewed. None of the 18
Health Insurance Portability and Accountability Act (HIPAA) identifiers for protected
health information were collected, and all charts reviewed were free of bias. The data
used in the study were securely destroyed after completion of the study.
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The risk for bias was minimized with the extraction of data being collected
through a computer program. A weakness of this study was the possibility that some
information was missed and not included. It was not possible to examine all patient
charts to see if to locate any missing data. Finally, the information in the chart is user
dependent. Some information may not have been entered, such as last dose of a
medication at home or pain scales.
Procedure
After approval to conduct the study was obtained from Lifespan and the Rhode
Island College Institutional Review Board, a request was sent to Informational Services
at the site to obtain the following information from patient records who underwent total
primary hip arthroplasty: age, gender, allergies, past medical history, home medications
(including last dose, date, and time taken), perioperative medications given, and inpatient
medications administered in the first 24 hours. The above data was a report previously
requested by the Department of Surgery at Lifespan which included patients who had a
total hip arthroplasty and revision at this facility. Data collection was narrowed down to
include only records from August 31, 2019 to December 31, 2016 per the approved IRB
protocol (Appendix C). The above data was accessed by a computer-generated system
that was placed under the “My Reports” section under Lifelinks, the hospital password
protected program for the researcher to review. Data were screened for inclusion and
exclusion criteria and the required data were extracted. Data collection began on January
25, 2020 and ended on March 13, 2020. No identifying data from the 18 HIPAA
identifiers was collected. The data was placed in an Excel spreadsheet and kept in a
password protected computer in a private office at the hospital facility. Data will be kept
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on an encrypted flash drive in a locked office and maintained for three years after the
completion of the study. Only a Lifespan password protected computer will be used.
The medications that were obtained from the inpatient records included opioids,
NSAIDS, acetaminophen, gabapentin, COX2 inhibitors (Celebrex), midazolam,
diphenhydramine, and antiemetics (ondansetron). The opioid medications included
fentanyl, hydromorphone, morphine, tramadol, Percocet, Vicodin, oxycodone, and
oxycontin. The NSAIDs included ibuprofen, ketorolac, meloxicam, and diclofenac. Any
NSAID, acetaminophen, COX2 inhibitor, or gabapentin taken at home within eight hours
of surgery was included. The search also included whether a spinal or general anesthetic
was administered and if a nerve block was performed. The patients’ pain scores in the
inpatient area was also collected.
For this study, the term preoperative referred to the time the patient arrived in the
preoperative area until they are transferred to the operating room. The term
intraoperative referred to their time in the operating room suite, and postoperative
referred to the time that the patient was in the recovery room. The inpatient hours
referred to the time the patient was considered recovered from anesthesia in PACU and
could be transferred to an inpatient bed. Perioperative referred to the time the patient
arrived in the preoperative area to the time the patient was discharged from the recovery
room area or post anesthesia care unit (PACU), not including the time documented as
Phase 2. When a patient had a prolonged recovery room time due to inability to obtain a
floor bed, then inpatient time began when the patient was placed in Phase 2 in the
recovery room. Phase 2 in the recovery room signifies that the patient had completed
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their immediate recovery room period, and had been cleared by the anesthesiologist for
transfer, but there was no bed available for the patient.
Data Measurement
Data (specified above) were collected and measured using Microsoft Excel. To
answer the research question, “Is there a difference in postoperative opioid requirements
in the first 24 inpatient hours in adult over the age of 60 who underwent primary hip
arthroplasty depending on the number of multimodal preoperative analgesics they
received?” total opioid consumption and nonopioids prescribed in the first 24 inpatient
hours along with pain levels were collected. A classification system was used to organize
the data. Data were categorized as Class 0 (no medication), Class 1 (1 nonopioid
medication), Class 2 (2 medications any type), Class 3 (3 medications any type), Class 4
(4 medications any type), and Class 5 (opioid only). Opioid consumption was converted
into morphine equivalents among the groups using Global RxPh opioid conversion
calculator (Global RxPh, n.d.). Postoperative pain scores were also compared between
the groups.
Data Analysis
Descriptive statistics were used to analyze the data to determine whether a certain
number of preoperative medications provided a greater reduction in postoperative opioid
use and lower pain scale scores. Data collected from a total of 200 medical charts were
analyzed using Microsoft Excel. The median, mode, and mean were evaluated and
compared against the different number of multimodal analgesics administered. The total
of all opioids administered were converted into morphine equivalents for comparison
using the Global RxPh opioid conversion calculator (Global RxPh, n.d.). This opioid
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conversion tool was utilized in the Ellis et al. (2018) research article, along with other
studies in the literature review. The data collected were analyzed and displayed using bar
graphs.
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Results
A total of 418 charts were reviewed until 200 qualifying charts were identified.
Females represented 54% (n=108) and males represented 46% (n=92) of the patients.
The breakdown of patients per age group were as follows: 45.5% (n=93) were 60-69
years old, 36% (n=72) were 70-79 years old, 16% (n=32) were 80-89 years old, and 1.5%
(n=3) were 90 years old or older. Analysis showed that 68% (n=136) of the qualifying
200 patients, did not receive any preoperative medications (Figure 4). Of the patients not
receiving preoperative medications, 5.1% (n=7) had written orders that were never
administered including one documented refusal. A total of 32% (n=64) patients received
some type of medication in the preoperative period (Figure 5). These medications
included one or any combination of the following; acetaminophen, COX2, gabapentin,
oxycodone, or oxycontin (Figure 4). In examining the charts, it was noted that some
patients received a dose of IV acetaminophen while in the operating room. These charts
were further examined to determine if the dose of IV acetaminophen was administered
prior to the first incision. The patients who received the IV acetaminophen prior to the
first incision were included in the analysis accounting for 28% (n= 18) of the patients
who received preoperative medication. All of these patients were categorized into Class
1.
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Figure 4
Patients per Class
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Figure 5
Postoperative Administration by Class
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Class 1 category comprised the largest number of patients. When the IV
acetaminophen prior to incision was included, it comprised 56% (n=36) of the patients

49

who received a preoperative multimodal. Of those patients, 86% (n=31) received
acetaminophen and 13.9% (n=5) received gabapentin preoperatively. The average
narcotic usage in the first 24 hours for Class 1 was 17.6 mg of morphine (Figure 6).
Figure 6
Class 1 Analgesic Breakdown
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administered over 24 hours
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Note. Class 1 Preoperative multimodal analgesic breakdown by combination
The analysis showed that patients who received two preoperative multimodal
medications, assigned as Class 2, required less opioid use in the first 24 hours
postoperatively. Only a small sample, 18.7% (n=12), received two preoperative
medications. The average narcotic usage was 7.5 mg of Morphine (Figure 7) in the first
24 hours postoperative. When those patients (n=12) were broken down by actual
medications given, the number in each group was too small to make any conclusions
about the combination of medications; 9 patients, 1 patient, 1 patient, and 1 patient in
each combination (Figure 7).
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Figure 7
Class 2 Analgesic Breakdown
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Note. Class 2 Preoperative multimodal analgesic breakdown by combination.
The Class 3 group 23.4% (n=15) received the second lowest consumption of
morphine totaling 13.8 mg of those that received preoperative medication. Despite the
small number, when that group was broken down, there was a significant difference in
the opioids administered between the groups. For example, patients who received
Tylenol (acetaminophen), a COX2, and an oxycodone preoperatively had significantly
lower opioid usage, compared to those who had Tylenol, gabapentin, and oxycontin, 5.4
mg and 19 mg respectively (Figure 8). Given this represents only 9.4% (n= 6) of the
sample who received preoperative medications, it is too small to draw any meaningful
conclusion.
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Figure 8
Class 3 Analgesic Breakdown
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Note. Class 3 preoperative multimodal analgesic breakdown by medication combinations.
No patients in the qualifying group received 4 preoperative multimodals, so no
data is presented in that column. There was only 1 patient who received an opioid only
as a preoperative analgesic 1.6% (n=1) of all patients receiving a preoperative
medication. That patient’s morphine equivalent was 15.83 mg in the 24 hours
postoperatively.
Roughly 10.5% (n=21) of the total patients received IV hydromorphone while in
phase 2. Standing PACU orders for pain are for hydromorphone, with oxycodone not
always being written as an option. Of those 21 patients, 14% (n=9) patients received a
preoperative medication. Seven of the nine patients were categorized in class 1, one in
class 2, and one was categorized in class 5. Since the conversion from hydromorphone to
morphine elicits a higher opioid usage than oxycodone, this may have affected some of

52

the opioid usage totals showing a higher morphine equivalent than if they were not
assigned to Phase 2 and were transferred when to an inpatient bed instead.
Pain scores were collected and analyzed on all patient groups postoperatively.
Pain scores were documented using the 0-10 Numeric Rating Scale Averages were
calculated and are illustrated in Figure 8. Class 2 showed the lowest pain scores but had
a standard deviation of 1.98. Conversely, Class 1 had the highest average documented
pain score of 5. Those who received zero, three, and five preoperative analgesics had
pain scores of 4.1, 4.4, and 4.2 respectively (Figure 9).
Figure 9
Inpatient Pain Scores
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Summary and Conclusions
The majority of the patients in this retrospective chart review who received a
preoperative analgesia received a dose of acetaminophen 89% (n=57). In the
retrospective chart review by Ladha et al. (2016), the authors found that only 65% of the
patients received a dose of acetaminophen the day of surgery. In this retrospective chart
review 97.5% (n=195) of the patients received a dose of acetaminophen the day of
surgery. This included perioperative and inpatient medications administered the day of
surgery. The patients who did not receive any acetaminophen 2.5% (n=5), three of the
patients had an order but refused the medication. Only one patient was not prescribed
postoperative acetaminophen, which included prn and standing orders. This aligns well
with the WHO pain ladder that recommends the use of nonopioid medications as a first
step (WHO, n.d.).
This retrospective chart review had limitations. A major barrier was obtaining
information from the medical chart. There were inconsistent documentations of home
medications, and the documentation of the first incision in the chart was not always
consistent with the actual time of the incision, rather the time documented was the same
time that was documented for the time the surgery ended. This excluded some charts in
which IV acetaminophen was administered in the OR from being utilized, since the time
of administration could not accurately be determined to be before the incision was made.
These charts were then assigned as IV acetaminophen being administered was
perioperative. Furthermore, there were cases in which the patient did not receive the
prescribed preoperative medication, and other cases where the patient received
preoperative acetaminophen and also received a second dose intraoperatively. These
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incidences possibly contributed to a smaller than actual patient population who received
preoperative medications and could have skewed the study findings.
When reviewing the charts, it was observed that the type of medication and dose
of medication prescribed were not totally dependent on a pain scale assessment. Pain
management prescriptions are not universal to all providers patients. It was noted that
some clinicians would prescribe for a nonopioid for pain rated as mild (0-4 on the
numeric pain scale), whereas others may oxycodone in varying doses. Given the wide
variations in dosing and types of medications prescribed, no definitive conclusion can be
made regarding pain levels and the number of preoperative multimodals administered. A
patient might have received two preoperative multimodals, but for pain considered
moderate, may have been prescribed 10 mg of oxycodone. Another patient with a
different physician who also received two preoperative multimodals may be prescribed
ketorolac for moderate pain.
The actual population of patients that received preoperative multimodal
medication was small 32% (n=64) which does not allow for any conclusive results.
However, the findings showed that when two multimodals were administered these
patients used the least dose of opioids postoperatively and had the lowest pain scores
compared to the other four classes. This suggests that by targeting the different pain
pathways, a patient will experience less pain. Overall, as a combined group they were
administered the smallest amount of postoperative opioid medications. When each class
was broken down by medications, class 3 that included acetaminophen, a COX 2, and
oxycodone required less opioids postoperatively. The percentage of preoperative
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medicated patients who received this combination, 9.4% (n= 6), was very small to
formulate a conclusive conclusion. It does however lend itself for further evaluation.
The charts that were reviewed were dated August 31, 2019 to the year 2016. The
recommendations from the Orthopedic Trauma Association were not published until May
2019. This study could be replicated comparing the results from after the guidelines were
published to the results before, to see if there has been a change in practice and a decrease
in total opioid usage.
Overall due to the small sample size and large variability between opioid
prescribing no conclusive results can be determined. An incidental finding while
examining the results, was that the groups who consumed the lower amounts of
postoperative opioids were more likely to have an order for around the clock
acetaminophen and ketorolac prescribed postoperatively. When ketorolac was ordered as
needed, the orders were prescriber dependent with variable pain scales used to determine
administration. The medication administered was also user dependent. Some patients
pain scale allowed for either an opioid or nonopioid for the same pain level, and there
was no clear documentation which treatment option the patient requested or if it were
determined by the nurse. This was an unexpected finding that was not part of the study.
These possible findings suggest that expanding the study may yield more conclusive
results
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Recommendations and Implications for Advanced Nursing Practice
The study revealed that despite the literature showing no analgesic advantage in
this situation to the administration of IV acetaminophen versus oral acetaminophen, the
IV version is still prescribed and is less cost effective. In this study, the percentage of
patients who received a dose of either oral of IV acetaminophen during the perioperative
period was 75%, and the percentage prescribed around the clock postoperative
acetaminophen was only 62%. The WHO pain ladder recommends nonopioids as the
first agent in pain control. Educating providers on the benefits of prescribing
acetaminophen postoperatively with follow up evaluation could have a significant
decrease in opioid administration postoperatively.
Advanced Practice Registered Nurses (APRN) are well positioned to educate
staff, develop and implement Enhanced Recovery Pathways to optimize patient outcomes
and decrease opioid use. The development of preoperative and postoperative surgery
specific order sets could be developed that align with the WHO guidelines for pain
management. The APRN is critical in the development of these due with their unique
professional relationship with working with physicians and nurses. With a more
consistent approach to medications ordered, medication and dosage ordered per pain,
further studies can be done to determine what medication combinations provide the best
pain relief while utilizing the least amount of narcotic. This study lends itself to further
examination of the preoperative administration of multimodals, and examination of the
effects on opioid usage with the administration of ketorolac postoperatively in pain
management.
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The Theory of Unpleasant Symptoms can be applied when reviewing data and
implementing changes. There may be the possibility that a COX2 preoperatively may
decrease postoperative opioid usage. Implementing a COX2 order into the preoperative
orders or prescribing it in the office to be administered at home prior to leaving for
surgery, could give more information on its potential benefits. Premedicating falls under
the physiological and psychological factors in the TOUS framework. The importance of
alleviating some of the unpleasant factors is paramount in achieving optimal patient
outcomes.
The APRN can promote evidence-based education to physicians and nurses. The
basis is improving the care and the quality of life for these patients. Serving as a resource
for staff and implementing education programs or leaflets for patients will enable them to
better understand the goals of pain management. With additional research the APRN can
identify barriers to achieving optimal pain management, and processes that resulted in
optimal patient outcomes.
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Appendix C: Protocol Data
Protocol Data
Upon Lifespan Institutional Review Board approval, medical records will be reviewed
to obtain a total of 100 qualifying cases. The review will begin with medical records
dated August 31, 2019 to December 31, 2016. The chart reviewal process will begin
after IRB approval date from Lifespan and the Rhode Island College.
Upon IRB approval, a request will be sent to Informational Services to obtain the
following information from patient records who underwent total primary hip
arthroplasty who are not deceased: age, gender, allergies, past medical history, home
medications which includes last dose date and time, perioperative medications given,
and inpatient medications in the first 24 hours. The medications obtained from inpatient
record will include opioids, NSAIDs, acetaminophen, gabapentin, COX2 inhibitors
(celecoxib), midazolam, diphenhydramine, and antiemetics (ondansetron). The opioid
medications will include fentanyl, hydromorphone, morphine, tramadol, Percocet,
Vicodin, oxycodone, and oxycontin. The NSAIDs will include ibuprofen, ketorolac,
meloxicam, and diclofenac. The search will include whether spinal or general
anesthesia was administered, and if a nerve blocks was performed. The patient’s pain
scores in the perioperative and inpatient areas will be in the perioperative and inpatient
areas will be collected.
Data will be received in deidentified form from Informational Services and will be
placed in the enclosed excel spreadsheet. All postoperative opioid dosages will be
converted to Morphine equivalents using the Global RxPh conversion tool
(https://globalrph.com/medcalcs/opioid-pain-management-converter-advanced/).
1. Approval from IRB from Lifespan and Rhode Island College
2. Submit request to IRB for information (age, gender, allergies, past medical
history, home medications with last date and dose time, perioperative
medications, inpatient medications in first 24 hours). Medications include
opioids, NSAIDs, acetaminophen, gabapentin, COX2 inhibitors (celecoxib),
midazolam, diphenhydramine, and antiemetics (ondansetron). The opioid
medications will include fentanyl, hydromorphone, morphine, tramadol,
Percocet, Vicodin, oxycodone, and oxycontin. The NSAIDs will include
ibuprofen, ketorolac, meloxicam, and diclofenac. Type of anesthesia
administered, and whether a block was administered.
3. Data will be placed into Excel Spreadsheet. (Submitted as data collection
tool).
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4. Opioid dosage will be converted to morphine equivalent dosages from
comparison.

